Surgical Laser cleared of patent infringement:
This article was originally published in Clinica
Executive Summary
The Central District of California Court has upheld Surgical Laser Technologies' motion that it did not infringe a patent owned by Trimedyne. The action, which concerns Trimedyne's hot metal tip, was filed in January 1995. As part of the same action, Trimedyne alleged Surgical Laser's side-firing, free- beam urologic probe infringes a patent for which Trimedyne holds the licence. Surgical Laser says it plans to bring a similar motion for summary judgment.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.